Prot #JKB-122AIH: A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis Patients who are Refractory or Intolerant to Current Therapies

Project: Research project

Project Details

StatusFinished
Effective start/end date5/19/165/19/19

Funding

  • Duke University (Prot # JKB-122AIH)
  • TaiwanJ Pharmaceuticals Co., Ltd. (Prot # JKB-122AIH)